Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Insulin-like growth factor I (IGF-I) has significant structural homology with insulin. IGF-I has been shown to bind to insulin receptors to stimulate glucose transport in fat and muscle, to inhibit hepatic glucose output and to lower blood glucose while simultaneously suppressing insulin secretion. However, the precise role of IGF-I in maintaining normal glucose homeostasis and insulin sensitivity is not well defined. Studies in patients with diabetes have shown that in insulin-deficient states, serum IGF-I concentrations are low and increase with insulin therapy. Similarly, administration of insulin via the portal vein results in optimization of plasma IGF-I concentrations. A patient with an IGF1 gene deletion was shown to have severe insulin resistance that improved with IGF-I therapy. Studies conducted in experimental animals have shown that if IGF-I synthesis by the liver is deleted, the animals become insulin-resistant, and this is improved when IGF-I is administered. Likewise, deletion of the IGF-I receptor in muscle in mice induces severe insulin resistance. Administration of IGF-I to patients with type 2 diabetes mellitus has been shown to result in an improvement in insulin sensitivity and a reduction in the requirement for exogenously administered insulin to maintain glucose homeostasis. A polymorphism in the IGF1 gene that has been shown to reduce serum IGF-I results in an increased prevalence of type 2 diabetes. Taken together, these findings support the conclusion that IGF-I is necessary for normal insulin sensitivity, and impairment of IGF-I synthesis results in a worsening state of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369 · cited 1×
“The extent to which IGF-I, as opposed to insulin, participates in this process under basal conditions has been difficult to define. There appear to be major differences among tissues in the capacity of IGF-I to exert these actions. Skeletal muscle is an insulin target tissue that appears to be particularly sensitive t…”
BackgroundMoses, A. C., Young, S. C., Morrow, L. A., O'Brien, M., & Clemmons, D. R. (1996) · Diabetes · doi:10.2337/diab.45.1.91 · Cited by 291 · cited 1×
“In this state, when serum IGFBP-1 concentrations are elevated because of transgenic forced overexpression, they develop impaired glucose tolerance and the blood glucose-lowering effect of an IGF-I injection is less than in control animals, suggesting that the binding protein is functioning to affect the ability of IGF…”
InfluentialSelf-citationCrossey, P. A., Jones, J. S., & Miell, J. P. (2000) · Diabetes · doi:10.2337/diabetes.49.3.457 · Cited by 72
Cited by
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Stroke incidence and prevalence in Europe: a review of available data
Truelsen, T., Piechowski‐Jóźwiak, B., Bonita, R., Mathers, C., Bogousslavsky, J., & Boysen, G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01138.x · Cited by 665
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409
“Since GH exerts powerful effects on carbohydrate and lipid metabolism (Clemmons, 2004; Davidson, 1987; LeRoith and Yakar, 2007), these findings also raise the possibility that inhibition of the GH axis contributes to the diverse metabolic actions of FGF21.”
BackgroundThe genetics of type 2 diabetes: what have we learned from GWAS?
Billings, L. K., & Florez, J. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05838.x · Cited by 389
Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models
Berryman, D. E., Christiansen, J. S., Johannsson, G., Thorner, M. O., & Kopchick, J. J. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.05.005 · Cited by 288
Metadata
- Authors
- Clemmons, D. R.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 62
- Issue
- Suppl. 1
- Pages
- 77-82
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2016326728
- Cited by
- 130
- References
- 3
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis. https://app.cochat.ai/papers/10.1159/000080763
- The paper
- Clemmons, D. R. (2004). Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis. Hormone Research in Paediatrics. https://doi.org/10.1159/000080763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.